SEC Filing Summary: Alphabet Inc. (Form 13F)
Business Context and Reporting Period
This filing is a Form 13F Information Table submitted by Alphabet Inc. for the reporting period ending December 31, 2024. The document discloses the equity securities held by the company at the end of the quarter. It is a regulatory disclosure of investment holdings and does not contain Alphabet's own operational financial results (e.g., revenue, profit, or cash flow).
Key Financial Metrics
The filing text does not provide Alphabet Inc.'s revenue, profit, cash flow, margins, debt, or liquidity metrics. Instead, it lists the value and share count of Alphabet's external equity portfolio. Key portfolio statistics derived from the table include:
- Portfolio Composition: The disclosed holdings are heavily concentrated in the biotechnology, healthcare, and technology sectors.
- Largest Holdings by Value:
- Planet Labs PBC: $129,048,270 (31,942,641 shares)
- Arm Holdings PLC: $241,882,314 (1,960,784 shares)
- Freshworks Inc. (Class A): $231,672,004 (14,327,273 shares)
- Revolution Medicines Inc.: $178,489,818 (4,080,700 shares)
- GitLab Inc.: $343,241,261 (6,091,238 shares)
- Voting Authority: Alphabet reports "Sole" voting authority for the majority of these positions, with some "Shared" authority noted for specific issuers like Freshworks and UiPath.
Material Changes
The filing text does not provide comparative data against the prior quarter (September 30, 2024). Therefore, material changes in position size, new acquisitions, or divestitures cannot be determined from this document alone.
Guidance, Outlook, and Risks
This Form 13F filing does not contain management commentary, forward-looking guidance, risk factors, or contingencies regarding Alphabet's core business operations. It is a static snapshot of holdings as of the reporting date.
Investor Verification Checklist
- Verify the total aggregate value of Alphabet's disclosed equity portfolio by summing the "Value" column, noting that this represents only a subset of potential holdings (e.g., private equity or non-reportable assets are excluded).
- Confirm the specific "Investment Discretion" codes (e.g., DFND 1, DFND 2) to understand the nature of the investment decision-making process for each holding.
- Cross-reference the share counts with public market data to validate the reported market values as of December 31, 2024.
- Review Alphabet's official 10-K or 10-Q filings for the actual financial performance (revenue, earnings, cash flow) of the company, as this document does not contain that data.